Latest Market News

Oct 20
D.A. Davidson downgrades Comerica to neutral on expectations that net interest income has peaked

D.A Davidson on Thursday cut its rating on financial services firm Comerica Inc. CMA, -1.91% to neutral from buy. Analyst Peter Winter said one main reason for the downgrade is that Comerica’s net interest income may peak in the fourth quarter, with some downside risk. He also cited deposit outflows that are “more than expected […]

Oct 20
American Airlines shares jump on 3Q results, robust guidance

American Airlines Group Inc. [s:aal] shares jumped 2.4% before market open, lifted by the company’s third-quarter results and robust fourth-quarter guidance. The carrier earned 69 cents a share on net income of $483 million, compared with a loss of 25 cents a share on net income of $169 million in the prior-year’s quarter. Excluding items, […]

Oct 20
Mobile bank N26 launches cryptocurrency trading with Bitpanda partnership

N26 Crypto is already available for Austrian customers and is planned to be rolled out in other key markets. 1099 Total views 21 Total shares The $9 billion-valuated German fintech N26 launched crypto trading on its mobile app. Starting from Austria and rolling out to other countries in the upcoming months, N26 Crypto will let […]

Oct 20
U.K. Prime Minister Liz Truss announces her resignation

In a brief statement, U.K. Prime Minister Liz Truss announced her resignation. Truss said she cannot deliver on the mandate she won in the Conservative election, and said a new leadership election will be held in a week. Betting markets suggest that Rishi Sunak, the former chancellor, may succeed her. The pound was stronger on […]

Oct 20
Nucor misses earnings target, shares fall

Nucor Corp NUE, -2.24% shares fell 4.8% in premarket trades after the steel company missed its third-quarter earnings target and said it’s facing more economic headwinds. Third-quarter earnings fell to $1.7 billion, or $6.50 a share, from $2.13 billion, or $7.28 a share in the year-ago quarter. Revenue increased to $10.5 billion from $10.31 billion, […]

Oct 20
Talaris Therapeutics’ stock falls 21% after reporting patient death in clinical trial

Shares of Talaris Therapeutics Inc. TALS, -37.81% tumbled 21.5% in premarket trading on Thursday after the company reported one of the participants in its Phase 3 study of living donor kidney transplant recipients died. The patient had been diagnosed with a moderate form of acute graft-vs-host disease. The trial’s oversight committee has said enrollment and […]